Stockreport

UPDATE 2-Neurocrine gets U.S. nod for Parkinson's therapy; COVID-19 delays launch [Reuters]

Neurocrine Biosciences, Inc.  (NBIX) 
Last neurocrine biosciences, inc. earnings: 2/4 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: neurocrine.com/about-us/webcasts-presentations
PDF UPDATE 2-Neurocrine gets U.S. nod for Parkinson's therapy; COVID-19 delays launch (Adds details on competition, analysts’ estimates on drug’s sales) By Dania Nadeem Apri [Read more]